However, cancers often evade immune detection through immune checkpoints, such as the cytotoxic T lymphocyte-associated protein 4 (CTLA-4), the programmed cell death protein-1 (PD-1), and the programmed cell death ligand-1 (PD-L1), which inhibit the physiological activation of T cells. The gene discussed is PDCD1; the disease is cancer.